ARTG 392894Self-care monitoring web-based application software
ARTG ID: 392894 · Roche Diabetes Care Australia Pty Ltd · mySugr GmbH · Class IIa · Started July 27, 2022
Good Name: Roche Diabetes Care Australia Pty Ltd - Self-care monitoring web-based application software
- Risk Class
- Class IIa
- Product Type
- Single Device Product
- ARTG Category
- General
- ARTG ID
- 392894
- Start Date
- July 27, 2022
- Effective Date
- July 27, 2022
- Name
- mySugr GmbH
- Country
- Austria
- Address
- Trattnerhof 1/5 OG, Wien, Vienna, 1010
An app that serves as a logbook that is used to support the treatment of diabetes through daily diabetes-related data management and aims to support the optimization of therapy. You can manually create log entries that include information about your insulin therapy, current & target blood sugar levels, carbohydrate intake & details of your activities. Additionally, you can synchronize other therapy devices such as blood sugar meters to mitigate errors caused by manually entering values and to better your confidence in usage.
Access comprehensive regulatory information for Self-care monitoring web-based application software in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is registered under ARTG number 392894 and sponsored by Roche Diabetes Care Australia Pty Ltd, manufactured by mySugr GmbH in Austria. The device registration started on July 27, 2022.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.